Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2025)
Biofrontera (BFRI) has 6 years of Total Non-Current Liabilities data on record, last reported at $17.2 million in Q3 2025.
- For Q3 2025, Total Non-Current Liabilities rose 50.75% year-over-year to $17.2 million; the TTM value through Sep 2025 reached $17.2 million, up 50.75%, while the annual FY2024 figure was $16.4 million, 13.27% down from the prior year.
- Total Non-Current Liabilities reached $17.2 million in Q3 2025 per BFRI's latest filing, down from $24.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $32.2 million in Q3 2023 and bottomed at -$16.6 million in Q2 2023.
- Average Total Non-Current Liabilities over 5 years is $19.6 million, with a median of $23.4 million recorded in 2023.
- Peak YoY movement for Total Non-Current Liabilities: crashed 158.54% in 2023, then surged 158.71% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $29.0 million in 2021, then decreased by 15.23% to $24.6 million in 2022, then decreased by 23.07% to $18.9 million in 2023, then fell by 13.27% to $16.4 million in 2024, then rose by 4.54% to $17.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $17.2 million in Q3 2025, $24.8 million in Q2 2025, and $15.4 million in Q1 2025.